Allan Barrett,Allan Barrett,Chow Chi-kin,Chow Chi-kin,Huang Lihua,Huang Lihua,Liu Ling,Liu Ling,Lu Jirong,Lu Jirong,Ng Kingman,Ng Kingman,Tetreault Jonathan Wendell,Tetreault Jonathan Wendell,Werner A
申请号：
SI200632258
公开号：
SI2481753T1
申请日:
2006.12.05
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
